/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 ÃÛÌÒÊÓƵ. en-US Fri, 16 May 2025 22:11:34 +0000 /lifesciences/articles/2341369?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341369 Initial public offerings are showing life again after a tariff-induced slumber, buoyed by strong debuts and a growing pipeline as more venture-backed technology startups are lining up public listings before Memorial Day and into June. Fri, 16 May 2025 22:01:21 +0000 /lifesciences/articles/2341459?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341459 A California federal jury found Friday that Johnson & Johnson's medical technology unit Biosense Webster violated federal and state antitrust laws by withholding clinical support to hospitals using third-party reprocessed catheters, awarding plaintiff Innovative Health more than $147 million in damages. Fri, 16 May 2025 21:38:53 +0000 /lifesciences/articles/2341222?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341222 Cancer treatment company Iovance Biotherapeutics has been hit with two proposed shareholder class actions accusing the company of misleading the public about the success of its commercial rollout of an FDA-approved skin cancer treatment. Fri, 16 May 2025 19:59:34 +0000 /lifesciences/articles/2341414?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341414 A proposed class of buyers of oral rinses is suing Colgate-Palmolive Co., alleging it misleadingly advertises its Hello Kids Fluoride Rinse as safe despite the U.S. Food and Drug Administration considering it too dangerous for children under 6 years old. Fri, 16 May 2025 19:14:49 +0000 /lifesciences/articles/2341400?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341400 Waterford Bank NA has objected to New Jersey drugmaker Nostrum Laboratories Inc.'s plan to sell an Ohio property, saying the bank doesn't want to be left to pay for the disposal of large quantities of controlled substances left at the site, an issue the parties are now negotiating ahead of a hearing next week. Fri, 16 May 2025 18:42:18 +0000 /lifesciences/articles/2341401?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341401 Biotechnology giant Illumina Inc. filed a lawsuit Thursday against Element Biosciences in Delaware federal court, accusing the company founded by former Illumina employees of infringing five patents related to automated gene sequencing technology. Fri, 16 May 2025 17:16:00 +0000 /lifesciences/articles/2341251?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341251 Prosecutors urged a Virginia federal judge Thursday to sentence a disbarred, former senior McKinsey & Co. partner to one year in prison for obstructing an investigation into the consulting giant's work with opioid-manufacturer Purdue Pharma, while defense counsel pushed for probation so that he can return to his home in Thailand. Fri, 16 May 2025 16:40:10 +0000 /lifesciences/articles/2340941?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340941 As Delaware's bill targeting hemp-derived THC beverages and ingestible products moves through the general assembly, it reads like a local regulatory fix — but in reality, it's a microcosm of a national power struggle playing out state-by-state across the cannabis frontier, says attorney Peter Murphy. Fri, 16 May 2025 16:32:23 +0000 /lifesciences/articles/2340246?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340246 Shook Hardy & Bacon LLP has expanded its Chicago office with the recent addition of an attorney with nearly 40 years of experience representing clients in mass tort matters and commercial disputes. Fri, 16 May 2025 14:52:03 +0000 /lifesciences/articles/2341343?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341343 A Rhode Island federal judge on Friday barred the Trump administration from cutting off billions of dollars in funding to state public health programs, determining the abrupt grant terminations likely violated congressional authority over spending. Fri, 16 May 2025 14:05:37 +0000 /lifesciences/articles/2341242?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341242 Biotechnology company BioMarin Pharmaceutical Inc., advised by Cooley LLP, on Friday announced plans to buy clinical-stage biopharmaceutical company Inozyme Pharma Inc., led by Goodwin Procter LLP, in a $270 million all-cash deal. Fri, 16 May 2025 13:40:03 +0000 /lifesciences/articles/2340809?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340809 The Trump administration has reached a $10,000 settlement with a consumer advocacy group over allegedly withholding information about the government's billion-dollar contracts with companies that developed and manufactured the COVID-19 vaccine, including Pfizer and Moderna. Fri, 16 May 2025 11:22:21 +0000 /lifesciences/articles/2339525?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2339525 A recent settlement of claims against law firm Eckert Seamans for allegedly abetting a Ponzi scheme underscores the continuing threat of clients who seek to exploit their lawyers in perpetrating fraud, and the critical importance of preemptive measures to avoid these clients, say attorneys at Lockton Companies. Thu, 15 May 2025 23:53:19 +0000 /lifesciences/articles/2340773?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340773 Biosense Webster's economic expert took the stand Thursday in California federal court to criticize Innovative Health's claim it suffered $147 million in damages from Biosense's policy withholding clinical support to hospitals using third-party reprocessed catheters, arguing Innovative lost nothing and saved on clinical support costs it otherwise would've incurred. Thu, 15 May 2025 23:11:19 +0000 /lifesciences/articles/2340754?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340754 A Seventh Circuit judge questioned whether a former AbbVie employee has plausibly alleged whistleblower retaliation in a false claims case and whether the drugmaker was holding his complaint to too high a standard Thursday as he explored whether a lower court's dismissal ruling should stand. Thu, 15 May 2025 19:57:44 +0000 /lifesciences/articles/2340011?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340011 A Singaporean pharmaceutical company is urging a North Carolina federal court to nix its order permitting Novo Nordisk AS to seek information bolstering its fraud claims stemming from an $800 million hypertension drug deal, saying the Danish drugmaker is improperly looking to prop up an ongoing arbitration instead. Thu, 15 May 2025 18:15:05 +0000 /lifesciences/articles/2340608?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340608 An attorney for protesters challenging their bans from the University of Michigan campus told a federal judge Thursday that the trespass orders have "upended" their lives because the vast campus intertwines with the city of Ann Arbor and urged the court to find the bans violated their due process. Thu, 15 May 2025 17:57:53 +0000 /lifesciences/articles/2339696?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2339696 As companies continue to implement generative artificial intelligence to enhance all phases of drug discovery, they must remain mindful of legal, regulatory and practical considerations as best practices in this space emerge and evolve, say attorneys at Sullivan & Cromwell. Thu, 15 May 2025 17:52:59 +0000 /lifesciences/articles/2339725?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2339725 Recent decisions from the Patent Trial and Appeal Board shed light on the varying extent to which the board considers patent owners' district court arguments, particularly with respect to the meaning of claim terms, say attorneys at Finnegan. Thu, 15 May 2025 17:46:07 +0000 /lifesciences/articles/2340326?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2340326 The makers of gastrointestinal drug Trulance have resolved their patent lawsuit, which sought to block several Mylan generic drugs from competing with the drug, in a confidential settlement agreement, according to a West Virginia federal court filing.